Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C

AE Bohte, A de Niet, L Jansen, S Bipat… - European …, 2014 - Springer
Objective To compare the diagnostic accuracy of TE and MRE and establish cutoff levels
and diagnostic strategies for both techniques, enabling selection of patients for liver biopsy …

Comparison of interobserver agreement of magnetic resonance elastography with histopathological staging of liver fibrosis

JH Runge, AE Bohte, J Verheij, V Terpstra… - Abdominal …, 2014 - Springer
Purpose MR elastography (MRE) can serve as an accurate surrogate marker of liver fibrosis.
For any diagnostic test that is to replace the current reference standard, interobserver …

[HTML][HTML] Association between the presence of metabolic comorbidities and liver-related events in patients with chronic hepatitis B

LA Patmore, WK Katwaroe, D van der Spek… - Clinical …, 2023 - Elsevier
Background & Aims Patients with chronic hepatitis B (CHB) are at increased risk of
hepatocellular carcinoma and (liver-related) mortality. In addition to hepatitis B–related …

Implementation of a multicenter biobanking collaboration for next‐generation sequencing‐based biomarker discovery based on fresh frozen pretreatment tumor tissue …

S Bins, GA Cirkel, CG Gadellaa‐Van Hooijdonk… - The …, 2017 - academic.oup.com
Background The discovery of novel biomarkers that predict treatment response in advanced
cancer patients requires acquisition of high‐quality tumor samples. As cancer evolves over …

[HTML][HTML] Identification of HCV resistant variants against direct acting antivirals in plasma and liver of treatment naïve patients

VS Raj, GB Hundie, AC Schürch, SL Smits, SD Pas… - Scientific Reports, 2017 - nature.com
Current standard-of-care treatment of chronically infected hepatitis C virus (HCV) patients
involves direct-acting antivirals (DAA). However, concerns exist regarding the emergence of …

[HTML][HTML] Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C

CJ Isfordink, SM Brakenhoff… - BMJ open …, 2020 - bmjopengastro.bmj.com
Background The Netherlands has a low hepatitis C virus (HCV) prevalence, estimated at
0.16%. Previous studies have shown that up to 30% of the diagnosed HCV population in the …

Genetic and clinical determinants of abdominal aortic diameter: genome-wide association studies, exome array data and Mendelian randomization study

E Portilla-Fernandez, D Klarin, SJ Hwang… - Human molecular …, 2022 - academic.oup.com
Progressive dilation of the infrarenal aortic diameter is a consequence of the ageing process
and is considered the main determinant of abdominal aortic aneurysm (AAA). We aimed to …

Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HB eAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up

MJH van Campenhout, WP Brouwer… - Journal of Viral …, 2019 - Wiley Online Library
Addition of peginterferon alpha (PEG‐IFN add‐on) to entecavir (ETV) treatment after a short
lead‐in phase results in more response than ETV monotherapy in HB eAg‐positive chronic …

The Rotterdam Study. Design update and major findings between 2020 and 2024

MA Ikram, BCT Kieboom, WP Brouwer… - European Journal of …, 2024 - Springer
Abstract The Rotterdam Study is a population-based cohort study, started in 1990 in the
district of Ommoord in the city of Rotterdam, the Netherlands, with the aim to describe the …

[HTML][HTML] Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe

LA Patmore, KMA van Eekhout, M Buti, ÖM Koc… - Journal of …, 2024 - Elsevier
Background & Aims Sub-Saharan African (SSA) ethnicity has been associated with a higher
risk of hepatocellular carcinoma (HCC) among individuals with chronic hepatitis B in cross …